爆料王 wins $19m in Cancer Institute NSW grants
The Cancer Institute NSW has awarded $19 million to 爆料王 scholars to advance fundamental and applied research, support the careers of promising researchers, and improve research infrastructure.聽
爆料王 scholars won 17 of the 34 grants and 50 percent of the $38 million funds awarded by Cancer Institute NSW.
Future Research Leader Fellow Dr Mark Larance was awarded $1 million and is returning from the UK鈥檚 University of Dundee to the 爆料王 to investigate how programs of intermittent fasting can assist with the prevention and treatment of cancer.
Career Development Fellow grant winner, 鈥� who first proved links between tanning beds and melanomas 鈥� is embarking on a new project to improve the disease鈥檚 treatment and prevention.
Career Development Fellow grant winner, was awarded $592,000 to progress her research on understanding the signaling mechanisms that cause inflammatory and malignant cancers, including glioblastoma.
The university鈥� four Early Career Fellows 鈥� , , (Centenary Institute and Honorary Associate,聽 爆料王) and at the ANZAC Research Institute鈥檚 Dendritic Cell Research group 鈥� won a total of $2 million. These grants aim to encourage the best researchers with no more than five years post-doctoral experience to choose cancer as their selected field of research.
The largest funding sums awarded to 爆料王 researchers is intended to progress the work of Translational Cancer Research Centres. These grants were made to ($6.5m) Director, NHMRC Clinical Trials Centre and Program Director, Sydney Catalyst Translational Research Centre, and medical oncologist, , Director, Director, Sydney West Cancer Network ($6.49m).
Eight researchers were awarded a total of $2.3 million in Research Infrastructure Grants aimed at supporting research platforms, core equipment and overall cancer research efforts. The University鈥檚 Research Infrastructure Grant recipients are: , , , , , , , and , who has appointments at the Chris O鈥橞rien Lifehouse and the Asbestos Diseases Research Institute.
Overall, allocated a total of $9.5 million to support the careers of cancer researchers, $3.8 million for research infrastructure and $25.9 million to support the state鈥檚 translational cancer research centres to advance research from bench to bedside.